Trials / Conditions / Epithelioid Mesothelioma
Epithelioid Mesothelioma
5 registered clinical trials studyying Epithelioid Mesothelioma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pan NCT04034238 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patien NCT03228537 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Malignant Mesothelioma NCT02399371 | University of Chicago | Phase 2 |
| Terminated | Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma NCT01861301 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleura NCT01064648 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |